Simvastatin Decreases Lipopolysaccharide-induced Pulmonary Inflammation in Healthy Volunteers
AUTOR(ES)
Shyamsundar, Murali
FONTE
American Thoracic Society
RESUMO
Rationale: Simvastatin inhibits inflammatory responses in vitro and in murine models of lung inflammation in vivo. As simvastatin modulates a number of the underlying processes described in acute lung injury (ALI), it may be a potential therapeutic option.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2695496Documentos Relacionados
- Lipopolysaccharide-induced apoptosis in swine lymphocytes in vivo.
- Protection against Lipopolysaccharide-Induced Death by Fluoroquinolones
- Lipopolysaccharide-induced leptin release is neurally controlled
- Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis
- Lipopolysaccharide-induced lethality and cytokine production in aged mice.